Details for Patent: 9,592,195

✉ Email this page to a colleague

Which drugs does patent 9,592,195 protect, and when does it expire?

Patent 9,592,195 protects BINOSTO and is included in one NDA.

This patent has twenty patent family members in sixteen countries.

Summary for Patent: 9,592,195

Patent landscape, scope, and claims:

Title:	Stable effervescent bisphosphonate formulations with rapid solubilization characteristics
Abstract:	A stable effervescent tablet, granule or powder composition free from excipients that may react with an effervescing organic acid component, comprising, an effective amount of a bisphosphonate bone resorption inhibitor, an effervescing organic acid component, an effervescing base component; wherein said composition is free of polyol binders and tableting lubricants; has a loss on drying of 0.25% (m/m) or less; has a complete disintegration time of no more than 180 seconds when placed in 3 to 8 fluid ounces of water at between 5-20.degree. C.; and said bisphosphonate is incorporated as a micronized particle or by spray drying and is completely solubdised in water within 2 minutes without stirring.
Inventor(s):	Hayward; Marshall A. (Bridgewater, NJ), Schmidt; Timo (Schindellegi, CH)
Assignee:	EffRx Pharmaceuticals SA (CH)
Application Number:	13/991,523
Patent Claim Types: see list of patent claims	Composition; Formulation; Compound; Dosage form;
More… ↓ ⤷ Subscribe

Drugs Protected by US Patent 9,592,195

Glossary

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Radius	BINOSTO	alendronate sodium	TABLET, EFFERVESCENT;ORAL	202344-001	Mar 12, 2012		RX	Yes	Yes	9,592,195	⤷ Subscribe	Y				⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 9,592,195

PCT Information
PCT Filed	December 05, 2011	PCT Application Number:	PCT/US2011/063341
PCT Publication Date:	June 14, 2012	PCT Publication Number:	WO2012/078528

International Family Members for US Patent 9,592,195

Subscribe to access the full database, or Subscribe
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2011338674	⤷ Subscribe
Brazil	112013010476	⤷ Subscribe
Canada	2820019	⤷ Subscribe
China	103140220	⤷ Subscribe
Denmark	2648702	⤷ Subscribe
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.